Hem › Medulloblastom › District of Columbia
Kliniska studier för Medulloblastom i District of Columbia
7 studier för Medulloblastom söker deltagare vid platser i District of Columbia.
Städer i District of Columbia
Officiell studietext (engelska)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- Children's National Hospital, Washington D.C.
RekryterarFas 1/2
Ålder 1 till 25 · Alla kön · Uppdaterad 28 sep. 2026 · NCT07346157Digoxin Medulloblastoma Study
- Children's National Medical Center, Washington D.C.
RekryterarFas 2
12 Months – 30 Years · Alla kön · Uppdaterad 26 aug. 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Children's National Medical Center, Washington D.C.
RekryterarFas 3
Ålder 4 till 21 · Alla kön · Uppdaterad 25 aug. 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's National Medical Center, Washington D.C.
RekryterarFas 2
Ålder 3 till 39 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05096481Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's National Hospital, Washington D.C.
Rekryterar
12 Months – 39 Years · Alla kön · Uppdaterad 11 aug. 2026 · NCT05057702Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- Children's National Hospital, Washington D.C.
RekryterarFas 1
Ålder 4 till 30 · Alla kön · Uppdaterad 7 aug. 2026 · NCT06514898Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
- Children's National Hospital, Washington D.C.
RekryterarFas 1
Ålder 1 till 30 · Alla kön · Uppdaterad 17 juni 2026 · NCT06193759Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.